Amanta Healthcare Limited

As of June 30, 2026, Amanta Healthcare Limited carries a market capitalization of 6.23B, placing it among publicly traded companies globally. Its enterprise value stands at 6.23B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Amanta Healthcare Limited has 38.83M shares outstanding.

As of June 30, 2026, Amanta Healthcare Limited trades at a trailing price-to-earnings ratio of 38.85.

As of June 30, 2026, Amanta Healthcare Limited trades at an EV/EBITDA multiple of 10.96 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.14 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 16.36 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 6.23B versus a market cap of 6.23B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 2.58M in revenue per employee across its workforce of 1,130.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Amanta Healthcare Limited recorded 60.12M in income tax expense. That works out to an effective tax rate of 29.06, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 206.90M, leaving 146.79M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Amanta Healthcare Limited's stock has gained approximately 30.12% over the past 52 weeks. The 50-day moving average sits at 185.75, while the 200-day moving average is 142.54.

Over the twelve months ended June 30, 2026, Amanta Healthcare Limited generated 2.91B in revenue and converted that into 146.79M in net income, yielding earnings per share of 4.13. EBITDA reached 568.76M, while operating income came in at 407.30M.

Over the twelve months ended June 30, 2026, Amanta Healthcare Limited posted a gross margin of 65.94, reflecting its pricing power and cost economics. The operating margin of 13.99 and net profit margin of 5.04 provide insight into operational efficiency.